These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12944232)

  • 1. The role and activities of the ISCT Regulatory Affairs Committee.
    Kelley L
    Cytotherapy; 2003; 5(4):279-83. PubMed ID: 12944232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT).
    Warkentin PI;
    Cytotherapy; 2003; 5(4):299-305. PubMed ID: 12944235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JACIE accreditation in Europe moves ahead.
    Kvalheim G; Gratwohl A; Urbano-Ispizua A;
    Cytotherapy; 2003; 5(4):306-8. PubMed ID: 12944236
    [No Abstract]   [Full Text] [Related]  

  • 4. Laying the regulatory path for advanced therapies.
    Nat Rev Drug Discov; 2008 Jun; 7(6):464-5. PubMed ID: 18511922
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulatory issues in cellular therapies.
    Sharp JG
    Cytotherapy; 2003; 5(4):277-8. PubMed ID: 12944231
    [No Abstract]   [Full Text] [Related]  

  • 6. Current regulatory issues in cell and tissue therapy.
    Burger SR
    Cytotherapy; 2003; 5(4):289-98. PubMed ID: 12944234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory aspects of cellular therapy product in Europe: JACIE accreditation in a processing facility.
    Caunday O; Bensoussan D; Decot V; Bordigoni P; Stoltz JF
    Biomed Mater Eng; 2009; 19(4-5):373-9. PubMed ID: 20042804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will regulation be the death of cell therapy in the United States?
    Gastineau DA
    Bone Marrow Transplant; 2004 Apr; 33(8):777-80. PubMed ID: 14968138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Banning "human cloning": a study in the difficulties of defining science.
    Greely HT
    South Calif Interdiscip Law J; 1998; 8(1):131-52. PubMed ID: 15085839
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Clin Lab Sci 21(2) D D Beck. May 20, 2008. Progress of the DCLS.
    Yu M
    Clin Lab Sci; 2008; 21(3):133. PubMed ID: 18678133
    [No Abstract]   [Full Text] [Related]  

  • 11. Standardization of cell analysis methods in clinical cellular therapy programs: A challenge for ISCT.
    Gratama J; Kvalheim G; Orfao A
    Cytotherapy; 2006; 8(6):528-9. PubMed ID: 17148028
    [No Abstract]   [Full Text] [Related]  

  • 12. Light, fast, and flexible: a new approach to regulation of human gene therapy.
    Cregan JA
    McGeorge Law Rev; 2000; 32(1):261-87. PubMed ID: 15709266
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of assisted reproductive technologies in the United States.
    Adamson D
    Fam Law Q; 2005; 39(3):727-44. PubMed ID: 16610154
    [No Abstract]   [Full Text] [Related]  

  • 14. [Standardization of laboratory medicine in Japan].
    Hamasaki N
    Rinsho Byori; 2009 Jun; 57(6):558-62. PubMed ID: 19621789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration.
    Phillips KA; Van Bebber SL
    Med Care Res Rev; 2006 Jun; 63(3):301-26. PubMed ID: 16651395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference: a critical analysis of the regulatory and ethical issues encountered in the development of a novel therapy.
    McKnight R
    Albany Law J Sci Technol; 2004; 15(1):73-108. PubMed ID: 17340758
    [No Abstract]   [Full Text] [Related]  

  • 17. Should the gold rule? Assessing "equivalent protections" for research participants across international borders.
    Sugarman J
    Hastings Cent Rep; 2005; 35(5):12-3. PubMed ID: 16295258
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
    Shani S; Yahalom Z
    Food Drug Law J; 2008; 63(3):701-11. PubMed ID: 19031669
    [No Abstract]   [Full Text] [Related]  

  • 19. Action Plan of the Clinical Affairs Committee - UEMS Physical and Rehabilitation Medicine Section: quality of care.
    Krokowski Gde K; Sjolund B; Quittan M; Kullmann L; Juocevicius A; Lejeune T; Giustini A; Lains J; McElligott J; Delarque A
    Eur J Phys Rehabil Med; 2009 Jun; 45(2):281-7. PubMed ID: 19209134
    [No Abstract]   [Full Text] [Related]  

  • 20. Cloning Californians? Report of the California Advisory Committee on Human Cloning and recent cloning-related legislation.
    Quintero MS
    Santa Clara Comput High Technol Law J; 2002 May; 18(2):417-31. PubMed ID: 15212073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.